1. Home
  2. JMSB vs CCCC Comparison

JMSB vs CCCC Comparison

Compare JMSB & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Marshall Bancorp Inc.

JMSB

John Marshall Bancorp Inc.

SELL

Current Price

$22.94

Market Cap

323.7M

Sector

Finance

ML Signal

SELL

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.05

Market Cap

350.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JMSB
CCCC
Founded
2005
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
323.7M
350.6M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
JMSB
CCCC
Price
$22.94
$3.05
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
★ $27.00
$12.63
AVG Volume (30 Days)
247.4K
★ 2.8M
Earning Date
10-28-2026
11-17-2026
Dividend Yield
★ 1.70%
N/A
EPS Growth
★ 24.17
16.45
EPS
★ 0.93
N/A
Revenue
N/A
★ $35,947,000.00
Revenue This Year
$16.55
N/A
Revenue Next Year
$148.88
N/A
P/E Ratio
$25.32
★ N/A
Revenue Growth
N/A
★ 1.02
52 Week Low
$18.82
$1.69
52 Week High
$24.26
$5.17

Technical Indicators

Market Signals
Indicator
JMSB
CCCC
Relative Strength Index (RSI) 58.22 48.64
Support Level $22.57 $2.88
Resistance Level $24.07 $3.25
Average True Range (ATR) 0.50 0.21
MACD 0.03 0.03
Stochastic Oscillator 67.16 50.90

Price Performance

Historical Comparison
JMSB
CCCC

About JMSB John Marshall Bancorp Inc.

John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: